Your browser doesn't support javascript.
loading
Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
Mitchell, Malcolm; Kothare, Prajakti; Bergstrom, Richard; Zhao, Fangyi; Jen, Kai Yu; Walker, Daniel; Johnson, Jason; McDonnell, David.
Afiliación
  • Mitchell M; Lilly Research Laboratories, Indianapolis, Indiana. Electronic address: mim@lilly.com.
  • Kothare P; Lilly Research Laboratories, Indianapolis, Indiana.
  • Bergstrom R; Indiana University School of Medicine, Indianapolis, Indiana.
  • Zhao F; Lilly Research Laboratories, Indianapolis, Indiana.
  • Jen KY; PharmaNet/i3, Indianapolis, Indiana.
  • Walker D; Lilly Research Laboratories, Indianapolis, Indiana.
  • Johnson J; Lilly Research Laboratories, Indianapolis, Indiana.
  • McDonnell D; Lilly Research Laboratories, Indianapolis, Indiana.
Clin Ther ; 35(12): 1890-908, 2013 Dec.
Article en En | MEDLINE | ID: mdl-24184052
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Benzodiazepinas Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Año: 2013 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Benzodiazepinas Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Año: 2013 Tipo del documento: Article